Vote Scores

Home / Companies / Voyager Therapeutics, Inc. / 5 Jun 2024

Meeting · year to 30 June 2024239 filers reporting

Voyager Therapeutics, Inc.: meeting of 5 Jun 2024

Votes reported on Form N-PX, item by item

239 Form N-PX filers reported votes at the Voyager Therapeutics, Inc. meeting of 5 Jun 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 60.1% of reported votes for; 54 filers withheld from or voted against at least one nominee.

543 vote records from 98 filers. 41 of the 98 filers that marked the item either way voted against management.

56.1% for0.0% against43.9% other41.8% against management98 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

353 vote records from 238 filers. 30 of the 232 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.

84.9% for11.8% against3.4% other12.9% against management238 filers92.7% for7.3% against7.3% against management30,469,925 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

181 vote records from 98 filers. 1 of the 98 filers that marked the item either way voted against management.

99.0% for1.0% against1.0% against management98 filers99.7% for0.3% against0.3% against management12,499,842 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalAbstain or withhold *ForFor
State Street and SPDRForForFor
American CenturyAbstain or withhold *Against *For
Franklin TempletonAbstain or withhold *ForFor
InvescoForAgainst *For
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsAbstain or withhold *ForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *Against *For
J.P. MorganNo reportForNo report
Goldman SachsAbstain or withhold *ForFor
WisdomTreeAbstain or withhold *ForFor
PGIM and PrudentialNo reportForNo report
Jackson National fundsAbstain or withhold *ForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialAbstain or withholdForFor
VoyaAbstain or withhold *ForFor
First TrustAbstain or withhold *ForFor
NationwideAbstain or withhold *Against *For
Victory CapitalAbstain or withhold *ForFor
Brighthouse FundsAbstain or withhold *ForFor
Guggenheim and RydexAbstain or withhold *ForFor
BNY MellonNo reportForNo report
PrincipalAbstain or withhold *ForFor
Pacific Life fundsForForFor
Global XForForFor
MFSAbstain or withhold *ForFor
Federated HermesForForFor
AllianceBernsteinNo reportForNo report
DWSAbstain or withhold *ForFor
AllspringAbstain or withhold *ForFor
VirtusAbstain or withhold *ForFor
Macquarie and Delaware FundsAbstain or withhold *ForFor
Janus HendersonNo reportForNo report
Neuberger BermanNo reportForNo report
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Voyager Therapeutics, Inc. meeting?

239 Form N-PX filers reported votes at the meeting of 5 Jun 2024. On say-on-pay, 30 of 232 voted against management (12.9%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Voyager Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Voyager Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Voyager Therapeutics, Inc. with a meeting date within three days of 5 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.